BX

Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration

Retrieved on: 
Monday, October 2, 2023
Biotechnology, Blackstone, Growth, Blackstone Credit, SOFR, Rare, Amicus Therapeutics, Therapy, Senior, BX, Patient, NYSE, Migalastat, Pharmaceutical industry, Management, Bank

PRINCETON, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel medicines for rare diseases, today announced that it has entered into a definitive agreement for a $430 million financing collaboration with funds managed by Blackstone (NYSE: BX). As part of the collaboration, Blackstone Life Sciences and Blackstone Credit have agreed to provide Amicus with a $400 million senior secured term loan facilitating a refinancing of existing debt and a $30 million strategic investment in Amicus’s common stock. The financing collaboration allows Amicus to grow revenues and move toward profitability while delivering on its mission for patients and its vision of being one of the leading biotechnology companies focused on rare diseases.

Key Points: 
  • PRINCETON, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel medicines for rare diseases, today announced that it has entered into a definitive agreement for a $430 million financing collaboration with funds managed by Blackstone (NYSE: BX).
  • As part of the collaboration, Blackstone Life Sciences and Blackstone Credit have agreed to provide Amicus with a $400 million senior secured term loan facilitating a refinancing of existing debt and a $30 million strategic investment in Amicus’s common stock.
  • The financing collaboration allows Amicus to grow revenues and move toward profitability while delivering on its mission for patients and its vision of being one of the leading biotechnology companies focused on rare diseases.
  • Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, stated: “This new financing with Blackstone strengthens our balance sheet and financial profile by reducing the interest rate versus our current debt, pushing out the amortization schedule and extending the amortization period.

CONTINUED INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Blackstone Inc.’s Directors and Officers for Breach of Fiduciary Duties – BX

Retrieved on: 
Wednesday, September 20, 2023
Law, Blackstone, PSSI, U.S. Department of Labor, Office of Inspector General, BX, DOL, NYSE, Blackstone Inc., Judgement, Management

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Blackstone Inc. (“Blackstone” or “Company”) (NYSE: BX) breached their fiduciary duties to Blackstone and its shareholders.

Key Points: 
  • NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Blackstone Inc. (“Blackstone” or “Company”) (NYSE: BX) breached their fiduciary duties to Blackstone and its shareholders.
  • If you are a Blackstone shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or [email protected] .
  • Scott+Scott is investigating whether members of Blackstone’s board of directors or senior management failed to manage Blackstone in an acceptable manner, in breach of their fiduciary duties to Blackstone, and whether Blackstone and its shareholders suffered damages as a result.
  • If you are a Blackstone shareholder, you may have legal claims against Blackstone’s directors and officers.

Blackstone Integrates Leading Credit and Insurance Businesses to Form Blackstone Credit and Insurance (BXCI) in Push Toward Next $1 Trillion

Retrieved on: 
Wednesday, September 13, 2023
Professional Services, Business, Insurance, Asset Management, Fintech, Consulting, Banking, Farm Credit System Insurance Corporation, BX, BDC, Blackstone Credit, Lisp (programming language), Growth, Entrepreneurship, Credit, Environment, NYSE, Financial services, Security (finance), Financial adviser

Blackstone (NYSE: BX) announced today the integration of its market-leading corporate credit, asset-based finance, and insurance groups into a single new unit, Blackstone Credit & Insurance (BXCI).

Key Points: 
  • Blackstone (NYSE: BX) announced today the integration of its market-leading corporate credit, asset-based finance, and insurance groups into a single new unit, Blackstone Credit & Insurance (BXCI).
  • Credit and Insurance is Blackstone’s fastest-growing segment – more than doubling to $295 billion in assets under management over the last three years.
  • BXCI will offer a one-stop solution across corporate and asset-based, as well as investment grade and non-investment grade, private credit.
  • Since Mr. Dellaert joined the firm in 2020, Blackstone has nearly tripled the assets it manages for insurance clients.

Vornado Realty Trust, Hudson Pacific, Blackstone, and New York City Economic Development Corporation to Create Public-Private Partnership and First Purpose-Built Studio Campus in Manhattan at Pier 94

Retrieved on: 
Tuesday, August 29, 2023
Entertainment, Film & Motion Pictures, TV and Radio, Commercial Building & Real Estate, Construction & Property, Urban Planning, REIT, Workforce, RBC, Partnership, BX, Studio, Sunset, VNO, Quality of life, Multimedia, Pier, City, Housing, Gold, LEED, Economic development, NYCEDC, Vornado Realty Trust, Times Square, Hudson Pacific Properties, Willets Point, Queens, Safety, NYSE, Television, Real estate, Nightclub, Industrial design, Film industry, Vornado, New York City Economic Development Corporation

Today, Vornado Realty Trust (NYSE: VNO), Hudson Pacific Properties (NYSE: HPP), Blackstone (NYSE: BX), the City of New York, and New York City Economic Development Corporation (NYCEDC) announced they have entered into Manhattan’s first public-private partnership venture to build a purpose-built studio campus at Pier 94.

Key Points: 
  • Today, Vornado Realty Trust (NYSE: VNO), Hudson Pacific Properties (NYSE: HPP), Blackstone (NYSE: BX), the City of New York, and New York City Economic Development Corporation (NYCEDC) announced they have entered into Manhattan’s first public-private partnership venture to build a purpose-built studio campus at Pier 94.
  • Vornado, who contributed its long-term leasehold for Pier 94 to the venture, will own 49.9%; Hudson Pacific will own 25.6%; and Blackstone’s institutional Core+ Real Estate strategy will own 24.5%.
  • Vornado will be responsible for development and Hudson Pacific will provide design oversight and manage the facility’s leasing and operations.
  • There will also be a program to support workforce development and training programs to connect local residents to opportunities in film, television, commercial and other media production.

CONTINUED INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Blackstone Inc.’s Directors and Officers for Breach of Fiduciary Duties – BX

Retrieved on: 
Monday, August 28, 2023
Law, Blackstone, PSSI, U.S. Department of Labor, Office of Inspector General, BX, DOL, NYSE, Blackstone Inc., Judgement, Management

NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Blackstone Inc. (“Blackstone” or “Company”) (NYSE: BX) breached their fiduciary duties to Blackstone and its shareholders.

Key Points: 
  • NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Blackstone Inc. (“Blackstone” or “Company”) (NYSE: BX) breached their fiduciary duties to Blackstone and its shareholders.
  • If you are a Blackstone shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or [email protected] .
  • Scott+Scott is investigating whether members of Blackstone’s board of directors or senior management failed to manage Blackstone in an acceptable manner, in breach of their fiduciary duties to Blackstone, and whether Blackstone and its shareholders suffered damages as a result.
  • If you are a Blackstone shareholder, you may have legal claims against Blackstone’s directors and officers.

Blackstone Announces Record Final Close for Fourth Flagship Tactical Opportunities Fund

Retrieved on: 
Monday, August 21, 2023
Banking, Asset Management, Professional Services, Finance, BX, Reef, Dislocation, Investment, Times Square, AI, NYSE, Geography, New Tradition

Blackstone (NYSE: BX) today announced that its Tactical Opportunities business closed its fourth flagship commingled fund, Blackstone Tactical Opportunities Fund IV (“BTO IV”), raising a record $5.2 billion of capital commitments.

Key Points: 
  • Blackstone (NYSE: BX) today announced that its Tactical Opportunities business closed its fourth flagship commingled fund, Blackstone Tactical Opportunities Fund IV (“BTO IV”), raising a record $5.2 billion of capital commitments.
  • Including other single-investor vehicles pursuing the same strategy, the combined BTO IV platform is currently expected to have nearly $10 billion of new capital in its fourth fundraising vintage.
  • This would be substantially higher than the BTO III platform ($4.2 billion for the flagship comingled fund, $8.7 billion inclusive of single-investor vehicles) and the largest-ever vintage of its kind.
  • Blackstone launched its Tactical Opportunities (Tac Opps) platform – a strategy the firm pioneered – in 2012 to invest across the landscape of private investment opportunities outside of traditional private equity and private credit.

Blackstone Closes Record Energy Transition Private Credit Fund at Over $7 Billion

Retrieved on: 
Thursday, August 10, 2023
Environment, Finance, Other Energy, Banking, Professional Services, Sustainability, Energy, Asset Management, Other Professional Services, BX, Blackstone Credit, AUM, Climate change, Platform, NYSE, Renewable energy

Blackstone (NYSE: BX) today announced the final close of its energy transition credit fund, Blackstone Green Private Credit Fund III (BGREEN III).

Key Points: 
  • Blackstone (NYSE: BX) today announced the final close of its energy transition credit fund, Blackstone Green Private Credit Fund III (BGREEN III).
  • BGREEN III closed at its hard cap of $7.1 billion, representing the largest energy transition private credit fund ever raised.
  • Dwight Scott, Global Head of Blackstone Credit, said: “Blackstone has built a premier platform focused on private credit in the energy transition and infrastructure markets.
  • We believe our experience and scale will enable Blackstone Credit to deliver flexible solutions to companies driving this historic transition and generate compelling returns for our investors.”
    BGREEN III is managed by Blackstone Credit’s Sustainable Resources Platform , which focuses on providing private credit to the renewable energy, infrastructure, and energy transition marketplace.

Third Annual Kubota Hometown Proud Sweepstakes Launches: Vote for Your Favorite Community Project for a Chance to WIN a Kubota Tractor or Mower

Retrieved on: 
Tuesday, August 1, 2023
Volunteering, Partnership, Housing, BX, Historically black colleges and universities, TSU, GROW, HBCU, Community Choice Aggregation, Tennessee State University, Agriculture, Farmer, Food safety, Hunger Task Force, Inc., Goodbread–Black Farm Historic District, Children's Village (New York), NO, Community, Local, City, Farm, Food, Heavy equipment, Tourism, Kubota, D.C

GRAPEVINE, Texas, Aug. 1, 2023 /PRNewswire/ -- As a continued commitment to its dealers, customers and local communities, Kubota Tractor Corporation announced five $100,000 grant recipients today in its third annual Kubota Hometown Proud™ grant program – aimed at providing much-needed support for cities, counties and nonprofit organizations and their unique initiatives across the country. Now, each of the five winners is put up for a public vote, and the hometown project with the most votes will win an additional $100,000 grant as the Kubota Community Choice Award winner. As an incentive, every vote submitted at KubotaHometownProud.com will be entered into a separate sweepstakes for the chance to win a Kubota zero-turn mower or BX sub-compact tractor.

Key Points: 
  • As an incentive, every vote submitted at KubotaHometownProud.com will be entered into a separate sweepstakes for the chance to win a Kubota zero-turn mower or BX sub-compact tractor.
  • Every vote submitted will be automatically entered into a sweepstakes* for the chance to win a Kubota residential Z200 Series zero-turn mower or BX Series sub-compact tractor.
  • The community project with the most votes will be announced as the Kubota Community Choice Award winner in September.
  • In March, Kubota announced its third annual Kubota Hometown Proud grant program, calling on cities, towns, municipalities, and nonprofits to apply for consideration.

The New York Women's Foundation Doubles Down on Investment to Advance Reproductive Justice, Safety & Healing Through Summer 2023 Grantmaking Efforts

Retrieved on: 
Wednesday, July 26, 2023
Laura Flanders, Pregnancy, Partnership, Move, Justice, Number of U.S. Supreme Court cases decided by year, Parent, Los Angeles LGBT Center, Woman, NYWF, Family separation, History, Movement, Mother, Organization, Investment, Risk, Child, FTG, Supreme court, Red Canary Song, GAC, New York Women's Foundation, FDA, Ecosystem, News, Safety, Birth control, BX

NEW YORK, July 26, 2023 /PRNewswire/ -- Today, The New York Women's Foundation (NYWF) announced $2.57 million of grantmaking in support of 34 organizations, both new and renewals to existing grantee partners, with a focus on reproductive justice, safety and healing, and emerging organizations and movements. For its June grants, The Foundation is investing in the infrastructure and sustainability of our communities and shaping our stories, while advancing its early investment strategy to create a more equitable and just future. As backlash against the movement for gender, racial, and economic justice continues, The Foundation acts in solidarity with partners by stepping up its investment in those closest to the issues.

Key Points: 
  • NEW YORK, July 26, 2023 /PRNewswire/ -- Today, The New York Women's Foundation (NYWF) announced $2.57 million of grantmaking in support of 34 organizations, both new and renewals to existing grantee partners, with a focus on reproductive justice, safety and healing, and emerging organizations and movements.
  • As backlash against the movement for gender, racial, and economic justice continues, The Foundation acts in solidarity with partners by stepping up its investment in those closest to the issues.
  • For the first time since the pandemic began, The Foundation engaged in a participatory grantmaking process in partnership with its Grants Advisory Committee (GAC).
  • The Foundation has a longstanding history of early investment as a core strategy, and these grants are a five-year commitment to these grassroots organizations.

Propanc Biopharma Produces Synthetic Recombinant Proenzymes for Cancer Therapy Targeting Advanced Solid Tumors

Retrieved on: 
Wednesday, July 5, 2023
Research, General Health, Pharmaceutical, Oncology, Genetics, Clinical Trials, Science, Surgery, Biotechnology, FDA, Other Science, Health, OTC Markets Group, PPCB, Pancreatic cancer, US Food Sovereignty Alliance, University, MB, Skin, Calendar, Cancer, Refrigeration, Breast, Brain, Prostate, POP1, Doctor of Philosophy, Lung, US, Protein, Bachelor of Medicine, Bachelor of Surgery, PRP, MD, Patient, Chymotrypsinogen, Natural Resources, Trypsinogen, Kidney, Liver, Growth, BX, US FDA, Pharmacology, Safety, Pharmaceutical industry, Vaccine, Microbiology

The program is designed to produce a backup clinical compound to the Company’s lead product candidate, PRP, which is from bovine origin, targeting metastatic cancer from solid tumors.

Key Points: 
  • The program is designed to produce a backup clinical compound to the Company’s lead product candidate, PRP, which is from bovine origin, targeting metastatic cancer from solid tumors.
  • According to Emergen Research, the global metastatic cancer market is projected to be worth over $111 Billion by 2027.
  • Furthermore, cell viability assays on pancreatic cancer stem cells (Bx PC3-CSCs) suggest that recombinant proenzymes may possess an even stronger anti-tumor effect than pancreatic proenzymes from bovine origin.
  • It started with a comprehensive assessment of our current level of understanding of proenzymes and then describes in detail recombinant technology, culminating in the successful production of a completely synthetic recombinant product.